$HITK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HI TECH PHARMACAL CO INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in HI TECH PHARMACAL CO INC. Get notifications about new insider transactions in HI TECH PHARMACAL CO INC for free.
Page: < prev 1 2 3 4 5 6 ... 6 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 8.31 | 1,406 | 11,684 | 1,406 | 0 to 1.4 K |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman-Busin ... | Option Exercise | A | 32.59 | 50,000 | 1,629,500 | 50,000 | |
| Jul 17 2012 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman-Busin ... | Gift | G | 0.00 | 700 | 0 | 541,160 | 541.9 K to 541.2 K (-0.13 %) |
| Jul 16 2012 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Option Exercise | M | 19.59 | 1,907 | 37,358 | 5,000 | |
| Jul 16 2012 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Option Exercise | M | 19.59 | 3,093 | 60,592 | 6,907 | |
| Jul 16 2012 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Option Exercise | M | 5.83 | 6,188 | 36,076 | 3,093 | |
| Jul 16 2012 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Option Exercise | M | 9.65 | 6,187 | 59,705 | 0 | |
| Jul 16 2012 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Option Exercise | M | 14.99 | 3,094 | 46,379 | 0 | |
| Jul 16 2012 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Sell | S | 29.33 | 1,907 | 55,932 | 0 | 1.9 K to 0 (-100.00 %) |
| Jul 16 2012 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Buy | M | 19.59 | 1,907 | 37,358 | 1,907 | 0 to 1.9 K |
| Jul 16 2012 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Sell | S | 27.75 | 18,562 | 515,096 | 0 | 18.6 K to 0 (-100.00 %) |
| Jul 16 2012 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Buy | M | 19.59 | 3,093 | 60,592 | 18,562 | 15.5 K to 18.6 K (+19.99 %) |
| Jul 16 2012 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Buy | M | 5.83 | 6,188 | 36,076 | 15,469 | 9.3 K to 15.5 K (+66.67 %) |
| Jul 16 2012 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Buy | M | 9.65 | 6,187 | 59,705 | 9,281 | 3.1 K to 9.3 K (+199.97 %) |
| Jul 16 2012 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Buy | M | 14.99 | 3,094 | 46,379 | 3,094 | 0 to 3.1 K |
| May 03 2012 | HITK | HI TECH PHARMACAL ... | Egbaria Kamel | Chief Scientific Of ... | Option Exercise | A | 33.54 | 40,000 | 1,341,600 | 40,000 | |
| Nov 14 2011 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | M | 3.84 | 56,250 | 216,000 | 0 | |
| Nov 14 2011 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | M | 4.29 | 11,250 | 48,263 | 0 | |
| Nov 14 2011 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Buy | M | 3.84 | 56,250 | 216,000 | 541,535 | 485.3 K to 541.5 K (+11.59 %) |
| Nov 14 2011 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Buy | M | 4.29 | 11,250 | 48,263 | 485,285 | 474 K to 485.3 K (+2.37 %) |
| Nov 14 2011 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Option Exercise | M | 3.84 | 112,500 | 432,000 | 0 | |
| Nov 14 2011 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Buy | M | 3.84 | 112,500 | 432,000 | 1,286,620 | 1.2 M to 1.3 M (+9.58 %) |
| Oct 11 2011 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 4.29 | 2,595 | 11,133 | 0 | |
| Oct 11 2011 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | J | 0.00 | 2,595 | 0 | 0 | 2.6 K to 0 (-100.00 %) |
| Oct 11 2011 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 4.29 | 2,595 | 11,133 | 2,595 | 0 to 2.6 K |
| Oct 11 2011 | HITK | HI TECH PHARMACAL ... | HIRSHAUT YASHAR | Director | Option Exercise | M | 4.29 | 11,250 | 48,263 | 0 | |
| Oct 11 2011 | HITK | HI TECH PHARMACAL ... | HIRSHAUT YASHAR | Director | Buy | M | 4.29 | 11,250 | 48,263 | 34,250 | 23 K to 34.3 K (+48.91 %) |
| Apr 29 2011 | HITK | HI TECH PHARMACAL ... | Egbaria Kamel | Chief Scientific Of ... | Option Exercise | A | 27.17 | 40,000 | 1,086,800 | 40,000 | |
| Dec 13 2010 | HITK | HI TECH PHARMACAL ... | Flynn James E | 10% Owner | Sell | S | 26.00 | 246 | 6,396 | 346,016 | 346.3 K to 346 K (-0.07 %) |
| Dec 13 2010 | HITK | HI TECH PHARMACAL ... | Flynn James E | 10% Owner | Sell | S | 26.00 | 154 | 4,004 | 210,662 | 210.8 K to 210.7 K (-0.07 %) |
| Dec 13 2010 | HITK | HI TECH PHARMACAL ... | Flynn James E | 10% Owner | Sell | S | 25.00 | 82,954 | 2,073,850 | 346,242 | 429.2 K to 346.2 K (-19.33 %) |
| Dec 13 2010 | HITK | HI TECH PHARMACAL ... | Flynn James E | 10% Owner | Sell | S | 25.00 | 51,646 | 1,291,150 | 210,816 | 262.5 K to 210.8 K (-19.68 %) |
| Dec 13 2010 | HITK | HI TECH PHARMACAL ... | Flynn James E | 10% Owner | Sell | S | 25.00 | 58,639 | 1,465,975 | 429,216 | 487.9 K to 429.2 K (-12.02 %) |
| Dec 13 2010 | HITK | HI TECH PHARMACAL ... | Flynn James E | 10% Owner | Sell | S | 25.00 | 36,538 | 913,450 | 262,462 | 299 K to 262.5 K (-12.22 %) |
| Dec 13 2010 | HITK | HI TECH PHARMACAL ... | Flynn James E | 10% Owner | Sell | S | 26.00 | 739 | 19,214 | 487,855 | 488.6 K to 487.9 K (-0.15 %) |
| Dec 13 2010 | HITK | HI TECH PHARMACAL ... | Flynn James E | 10% Owner | Sell | S | 26.00 | 461 | 11,986 | 299,000 | 299.5 K to 299 K (-0.15 %) |
| Nov 15 2010 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Option Exercise | A | 22.25 | 10,000 | 222,500 | 10,000 | |
| Nov 15 2010 | HITK | HI TECH PHARMACAL ... | Caskey Davis S | Officer | Option Exercise | A | 22.25 | 5,000 | 111,250 | 5,000 | |
| Nov 15 2010 | HITK | HI TECH PHARMACAL ... | Harvey Bryce M | Officer | Option Exercise | A | 22.25 | 5,000 | 111,250 | 5,000 | |
| Nov 15 2010 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Vice Chairman-Busin ... | Option Exercise | A | 22.25 | 95,000 | 2,113,750 | 95,000 | |
| Nov 12 2010 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Option Exercise | A | 22.25 | 7,500 | 166,875 | 7,500 | |
| Nov 12 2010 | HITK | HI TECH PHARMACAL ... | Van Hulst Jack | Director | Option Exercise | A | 22.25 | 10,000 | 222,500 | 10,000 | |
| Nov 12 2010 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Option Exercise | A | 22.25 | 30,000 | 667,500 | 30,000 | |
| Nov 12 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | A | 22.25 | 10,000 | 222,500 | 10,000 | |
| Nov 12 2010 | HITK | HI TECH PHARMACAL ... | PUGLISI ANTHONY J | Director | Option Exercise | A | 22.25 | 10,000 | 222,500 | 10,000 | |
| Nov 12 2010 | HITK | HI TECH PHARMACAL ... | HIRSHAUT YASHAR | Director | Option Exercise | A | 22.25 | 10,000 | 222,500 | 10,000 | |
| Nov 12 2010 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Option Exercise | A | 22.25 | 50,000 | 1,112,500 | 50,000 | |
| Nov 12 2010 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Gift | G | 0.00 | 6,000 | 0 | 1,173,620 | 1.2 M to 1.2 M (-0.51 %) |
| Oct 07 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 13.50 | 1,000 | 13,500 | 10,375 | |
| Oct 07 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 4.29 | 1,290 | 5,534 | 2,595 | |
| Oct 07 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 8.31 | 2,512 | 20,875 | 4,238 | |
| Oct 07 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | S | 21.22 | 1,000 | 21,220 | 0 | 1,000 to 0 (-100.00 %) |
| Oct 07 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 13.50 | 1,000 | 13,500 | 1,000 | 0 to 1,000 |
| Oct 07 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | J | 0.00 | 1,290 | 0 | 0 | 1.3 K to 0 (-100.00 %) |
| Oct 07 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 4.29 | 1,290 | 5,534 | 1,290 | 0 to 1.3 K |
| Oct 07 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | J | 0.00 | 2,512 | 0 | 0 | 2.5 K to 0 (-100.00 %) |
| Oct 07 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 8.31 | 2,512 | 20,875 | 2,512 | 0 to 2.5 K |
| Sep 22 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 5.83 | 947 | 5,521 | 10,303 | |
| Sep 22 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | J | 0.00 | 947 | 0 | 0 | 947 to 0 (-100.00 %) |
| Sep 22 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 5.83 | 947 | 5,521 | 947 | 0 to 947 |
| Sep 20 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 13.50 | 1,000 | 13,500 | 10,375 | |
| Sep 20 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 1.92 | 2,358 | 4,527 | 0 | |
| Sep 20 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | S | 20.84 | 1,000 | 20,840 | 0 | 1,000 to 0 (-100.00 %) |
| Sep 20 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 13.50 | 1,000 | 13,500 | 1,000 | 0 to 1,000 |
| Sep 20 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | J | 0.00 | 2,358 | 0 | 0 | 2.4 K to 0 (-100.00 %) |
| Sep 20 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 1.92 | 2,358 | 4,527 | 2,358 | 0 to 2.4 K |
| Sep 15 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 10.93 | 1,956 | 21,379 | 7,419 | |
| Sep 15 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | S | 20.22 | 1,956 | 39,550 | 0 | 2 K to 0 (-100.00 %) |
| Sep 15 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 10.93 | 1,956 | 21,379 | 1,956 | 0 to 2 K |
| Jul 23 2010 | HITK | HI TECH PHARMACAL ... | Harvey Bryce M | Officer | Option Exercise | M | 5.83 | 1,250 | 7,288 | 3,750 | |
| Jul 23 2010 | HITK | HI TECH PHARMACAL ... | Harvey Bryce M | Officer | Option Exercise | M | 9.93 | 2,500 | 24,825 | 2,500 | |
| Jul 23 2010 | HITK | HI TECH PHARMACAL ... | Harvey Bryce M | Officer | Sell | S | 20.49 | 950 | 19,466 | 0 | 950 to 0 (-100.00 %) |
| Jul 23 2010 | HITK | HI TECH PHARMACAL ... | Harvey Bryce M | Officer | Sell | S | 20.49 | 2,800 | 57,383 | 950 | 3.8 K to 950 (-74.67 %) |
| Jul 23 2010 | HITK | HI TECH PHARMACAL ... | Harvey Bryce M | Officer | Buy | M | 5.83 | 1,250 | 7,288 | 3,750 | 2.5 K to 3.8 K (+50.00 %) |
| Jul 23 2010 | HITK | HI TECH PHARMACAL ... | Harvey Bryce M | Officer | Buy | M | 9.93 | 2,500 | 24,825 | 2,500 | 0 to 2.5 K |
| Jul 20 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 10.93 | 3,000 | 32,790 | 9,375 | |
| Jul 20 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | S | 20.46 | 3,000 | 61,380 | 0 | 3 K to 0 (-100.00 %) |
| Jul 20 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 10.93 | 3,000 | 32,790 | 3,000 | 0 to 3 K |
| Apr 28 2010 | HITK | HI TECH PHARMACAL ... | Egbaria Kamel | Chief Scientific Of ... | Option Exercise | A | 23.10 | 40,000 | 924,000 | 40,000 | |
| Apr 15 2010 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 24.25 | 20,000 | 485,000 | 473,535 | 493.5 K to 473.5 K (-4.05 %) |
| Apr 15 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 1.92 | 466 | 895 | 2,358 | |
| Apr 15 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | J | 0.00 | 466 | 0 | 0 | 466 to 0 (-100.00 %) |
| Apr 15 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 1.92 | 466 | 895 | 466 | 0 to 466 |
| Apr 14 2010 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Option Exercise | M | 10.68 | 6,250 | 66,750 | 6,250 | |
| Apr 14 2010 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Sell | S | 23.39 | 6,250 | 146,188 | 0 | 6.3 K to 0 (-100.00 %) |
| Apr 14 2010 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Buy | M | 10.68 | 6,250 | 66,750 | 6,250 | 0 to 6.3 K |
| Apr 09 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 13.50 | 1,000 | 13,500 | 11,375 | |
| Apr 09 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | M | 8.31 | 1,750 | 14,543 | 6,750 | |
| Apr 09 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | S | 22.65 | 1,000 | 22,650 | 0 | 1,000 to 0 (-100.00 %) |
| Apr 09 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 13.50 | 1,000 | 13,500 | 1,000 | 0 to 1,000 |
| Apr 09 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Sell | S | 22.59 | 1,750 | 39,533 | 0 | 1.8 K to 0 (-100.00 %) |
| Apr 09 2010 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Buy | M | 8.31 | 1,750 | 14,543 | 1,750 | 0 to 1.8 K |
| Apr 09 2010 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 22.58 | 25,000 | 564,500 | 1,179,620 | 1.2 M to 1.2 M (-2.08 %) |
| Apr 09 2010 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 22.52 | 25,000 | 563,000 | 1,204,620 | 1.2 M to 1.2 M (-2.03 %) |
| Mar 29 2010 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Option Exercise | M | 1.78 | 112,500 | 200,250 | 0 | |
| Mar 29 2010 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 22.94 | 35,000 | 802,900 | 1,229,620 | 1.3 M to 1.2 M (-2.77 %) |
| Mar 29 2010 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Sell | S | 21.95 | 15,000 | 329,250 | 1,264,620 | 1.3 M to 1.3 M (-1.17 %) |
| Mar 29 2010 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Buy | M | 1.78 | 112,500 | 200,250 | 1,279,620 | 1.2 M to 1.3 M (+9.64 %) |
| Jan 19 2010 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | M | 1.78 | 26,250 | 46,725 | 0 | |
| Jan 19 2010 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Sell | S | 25.70 | 26,250 | 674,625 | 493,535 | 519.8 K to 493.5 K (-5.05 %) |
| Jan 19 2010 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Buy | M | 1.78 | 26,250 | 46,725 | 519,785 | 493.5 K to 519.8 K (+5.32 %) |
| Jan 07 2010 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Option Exercise | M | 19.95 | 2,517 | 50,214 | 4,983 | |
| Jan 07 2010 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Sell | S | 29.02 | 2,517 | 73,043 | 0 | 2.5 K to 0 (-100.00 %) |
| Jan 07 2010 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Buy | M | 19.95 | 2,517 | 50,214 | 2,517 | 0 to 2.5 K |
| Jan 07 2010 | HITK | HI TECH PHARMACAL ... | PUGLISI ANTHONY J | Director | Option Exercise | M | 10.93 | 15,000 | 163,950 | 0 | |
| Jan 07 2010 | HITK | HI TECH PHARMACAL ... | PUGLISI ANTHONY J | Director | Sell | S | 28.97 | 800 | 23,176 | 0 | 800 to 0 (-100.00 %) |
| Jan 07 2010 | HITK | HI TECH PHARMACAL ... | PUGLISI ANTHONY J | Director | Sell | S | 28.90 | 14,200 | 410,380 | 800 | 15 K to 800 (-94.67 %) |
| Jan 07 2010 | HITK | HI TECH PHARMACAL ... | PUGLISI ANTHONY J | Director | Buy | M | 10.93 | 15,000 | 163,950 | 15,000 | 0 to 15 K |
| Dec 30 2009 | HITK | HI TECH PHARMACAL ... | Van Hulst Jack | Director | Option Exercise | M | 5.83 | 3,094 | 18,038 | 9,281 | |
| Dec 30 2009 | HITK | HI TECH PHARMACAL ... | Van Hulst Jack | Director | Sell | S | 28.34 | 3,094 | 87,673 | 0 | 3.1 K to 0 (-100.00 %) |
| Dec 30 2009 | HITK | HI TECH PHARMACAL ... | Van Hulst Jack | Director | Buy | M | 5.83 | 3,094 | 18,038 | 3,094 | 0 to 3.1 K |
| Dec 16 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Option Exercise | M | 5.83 | 6,250 | 36,438 | 18,750 | |
| Dec 16 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Sell | S | 22.34 | 5,350 | 119,519 | 0 | 5.4 K to 0 (-100.00 %) |
| Dec 16 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Sell | S | 24.27 | 900 | 21,843 | 5,350 | 6.3 K to 5.4 K (-14.40 %) |
| Dec 16 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Buy | M | 5.83 | 6,250 | 36,438 | 6,250 | 0 to 6.3 K |
| Dec 15 2009 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Option Exercise | M | 5.83 | 3,094 | 18,038 | 9,281 | |
| Dec 15 2009 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Option Exercise | M | 9.65 | 3,094 | 29,857 | 6,187 | |
| Dec 15 2009 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Option Exercise | M | 14.99 | 9,281 | 139,122 | 3,094 | |
| Dec 15 2009 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Sell | S | 23.29 | 15,469 | 360,273 | 0 | 15.5 K to 0 (-100.00 %) |
| Dec 15 2009 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Buy | M | 5.83 | 3,094 | 18,038 | 15,469 | 12.4 K to 15.5 K (+25.00 %) |
| Dec 15 2009 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Buy | M | 9.65 | 3,094 | 29,857 | 12,375 | 9.3 K to 12.4 K (+33.34 %) |
| Dec 15 2009 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Buy | M | 14.99 | 9,281 | 139,122 | 9,281 | 0 to 9.3 K |
| Dec 15 2009 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Option Exercise | M | 5.83 | 1,875 | 10,931 | 5,625 | |
| Dec 15 2009 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Option Exercise | M | 10.68 | 1,250 | 13,350 | 3,750 | |
| Dec 15 2009 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Option Exercise | M | 10.93 | 2,500 | 27,325 | 2,500 | |
| Dec 15 2009 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Option Exercise | M | 12.05 | 18,750 | 225,938 | 0 | |
| Dec 15 2009 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Option Exercise | M | 10.62 | 11,250 | 119,475 | 0 | |
| Dec 15 2009 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Option Exercise | M | 14.99 | 22,500 | 337,275 | 0 | |
| Dec 15 2009 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Sell | S | 23.75 | 16,225 | 385,344 | 0 | 16.2 K to 0 (-100.00 %) |
| Dec 15 2009 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Sell | S | 22.81 | 41,900 | 955,739 | 16,225 | 58.1 K to 16.2 K (-72.09 %) |
| Dec 15 2009 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Buy | M | 5.83 | 1,875 | 10,931 | 58,125 | 56.3 K to 58.1 K (+3.33 %) |
| Dec 15 2009 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Buy | M | 10.68 | 1,250 | 13,350 | 56,250 | 55 K to 56.3 K (+2.27 %) |
| Dec 15 2009 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Buy | M | 10.93 | 2,500 | 27,325 | 55,000 | 52.5 K to 55 K (+4.76 %) |
| Dec 15 2009 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Buy | M | 12.05 | 18,750 | 225,938 | 52,500 | 33.8 K to 52.5 K (+55.56 %) |
| Dec 15 2009 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Buy | M | 10.62 | 11,250 | 119,475 | 33,750 | 22.5 K to 33.8 K (+50.00 %) |
| Dec 15 2009 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Buy | M | 14.99 | 22,500 | 337,275 | 22,500 | 0 to 22.5 K |
| Nov 16 2009 | HITK | HI TECH PHARMACAL ... | SELTZER REUBEN | Director | Option Exercise | A | 19.59 | 25,000 | 489,750 | 25,000 | |
| Nov 16 2009 | HITK | HI TECH PHARMACAL ... | HIRSHAUT YASHAR | Director | Option Exercise | A | 19.59 | 10,000 | 195,900 | 10,000 | |
| Nov 16 2009 | HITK | HI TECH PHARMACAL ... | Harvey Bryce M | Officer | Option Exercise | A | 19.59 | 5,000 | 97,950 | 5,000 | |
| Nov 16 2009 | HITK | HI TECH PHARMACAL ... | Simpson Bruce W | Director | Option Exercise | A | 19.59 | 10,000 | 195,900 | 10,000 | |
| Nov 16 2009 | HITK | HI TECH PHARMACAL ... | Van Hulst Jack | Director | Option Exercise | A | 19.59 | 10,000 | 195,900 | 10,000 | |
| Nov 16 2009 | HITK | HI TECH PHARMACAL ... | GOLDWYN MARTIN M | Director | Option Exercise | A | 19.59 | 10,000 | 195,900 | 10,000 | |
| Nov 16 2009 | HITK | HI TECH PHARMACAL ... | April Gary M | President, HCP Divi ... | Option Exercise | A | 19.59 | 7,500 | 146,925 | 7,500 | |
| Nov 16 2009 | HITK | HI TECH PHARMACAL ... | PETERS WILLIAM J | VP and Chief Financ ... | Option Exercise | A | 19.59 | 25,000 | 489,750 | 25,000 | |
| Nov 16 2009 | HITK | HI TECH PHARMACAL ... | Caskey Davis S | Officer | Option Exercise | A | 19.59 | 5,000 | 97,950 | 5,000 | |
| Nov 16 2009 | HITK | HI TECH PHARMACAL ... | SELTZER DAVID S | CEO, President, Sec ... | Option Exercise | A | 19.59 | 50,000 | 979,500 | 50,000 | |
| Nov 13 2009 | HITK | HI TECH PHARMACAL ... | PUGLISI ANTHONY J | Director | Option Exercise | A | 19.59 | 10,000 | 195,900 | 10,000 | |
| Oct 16 2009 | HITK | HI TECH PHARMACAL ... | HIRSHAUT YASHAR | Director | Option Exercise | M | 1.92 | 11,250 | 21,600 | 0 | |
| Oct 16 2009 | HITK | HI TECH PHARMACAL ... | HIRSHAUT YASHAR | Director | Option Exercise | M | 2.00 | 6,750 | 13,500 | 0 | |
| Oct 16 2009 | HITK | HI TECH PHARMACAL ... | HIRSHAUT YASHAR | Director | Sell | S | 24.50 | 11,250 | 275,625 | 23,000 | 34.3 K to 23 K (-32.85 %) |